Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RASSF1A in maternal plasma as a molecular marker of preeclampsia

22 Mar 2013

Abstract excerpt

OBJECTIVES: This study aimed to quantitate cell free (cf) and cell free fetal (cff) DNA in maternal plasma by determining RASSF1A levels before and after enzyme digestion in women who subsequently developed preeclampsia (PE) and compare them with uncomplicated pregnancies. METHODS: Twenty-four samples from pregnant women who developed PE and 48 samples from women with uncomplicated pregnancies were analysed....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23526657
DOI: 10.1002/pd.4093

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RASSF1A in maternal plasma as a molecular marker of preeclampsiaPMID 23526657Read ↗

Quantification and application of the placental epigenetic signature of the <i>RASSF1A</i> gene in maternal plasmaSemantic proximity Read ↗

Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal DiagnosisSemantic proximity Read ↗

Quantitative aberrations of hypermethylated <i>RASSF1A</i> gene sequences in maternal plasma in pre‐eclampsiaSemantic proximity Read ↗

Quantification of Cell-Free DNA in Normal and Complicated Pregnancies: Overcoming Biological and Technical IssuesSemantic proximity Read ↗

Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.Semantic proximity Read ↗

RASSF1A Promoter Methylation Patterns in the Pathogenesis of PreeclampsiaSemantic proximity Read ↗

Cell-free fetal DNA and pregnancy-related complications (Review)Semantic proximity Read ↗

Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.Semantic proximity Read ↗

Association between fetal fraction on cell‐free DNA testing and first‐trimester markers for pre‐eclampsiaSemantic proximity Read ↗

Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal FactorsSemantic proximity Read ↗

Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profilingSemantic proximity Read ↗

Cell-free DNA Methylation and Transcriptomic Signature Prediction of Pregnancies with Adverse OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.